rhinoplasty.cc
Menu

Journal archive · by topic

Non-surgical and filler rhinoplasty

88 papers with rhinoplasty in the title matching this topic, 2012 to 2026.

88
Papers
40
Start here
64
Abstracts on file
25
Open access
9
Journals
2012
First year
2026
Latest year
64
Summaries written
APS29PRS14FPS10FPSAM10PRS-GO8FPS Clin7ASJ6CPS3JAMA FPS1
2201212013120141201532016220175201882019720201120211120222202311202417202562026

What the literature says

Synthesised from the abstracts of the 40 papers listed under Start here. Every line carries the PubMed ID it rests on.

Two-sentence lead. Filler rhinoplasty produces satisfaction of 92-99% in pooled series with mostly mild side effects, but about 0.2-0.3% of patients suffer arterial occlusion, skin necrosis ran 0.06% in 5,000 primary treatments and 0.47% in 2,088 post-surgical corrections, and vision loss when it happens is usually immediate and permanent. Risk is higher after prior surgical rhinoplasty, the bridge is the most common injection site in reported blindness cases, effect lasts 6 to 14 months, and 74% of surveyed European surgeons now operate on noses that carry filler.

Key points

  • Systematic review, 30 studies (n=9657): hyaluronic acid in 96.76%, calcium hydroxyapatite 1.22%; satisfaction 99.08%; complications 39.11%, mostly erythema and swelling (27.95%); severe arterial occlusion 0.27% [38862661]
  • Single-injector safety review, 2275 patients / 2488 procedures over 10 years: adverse event rate 7.6%; serious (ischemia, necrosis) 5 cases (0.20%); prior surgical rhinoplasty raised AE rate to 10.8% vs 7.4%, OR 1.51 (95% CI 1.03-2.18), p=0.032; tip and sidewall had the highest AE rates [33270519]
  • Vision loss after nasal filler, 21 articles / 22 cases: mean age 33.4; 90.9% female; hyaluronic acid in 50%; onset immediate in 82%; nasal bridge/dorsum the site in 12 (57%), glabella in 6 (29%); full recovery in 27%, averaging 5.3 months [42660550]
  • Treatments reported for vision loss: hyaluronidase, corticosteroids, antibiotics; loss "often immediate and irreversible despite treatment"; hyperbaric oxygen "showed promise" [42660550]
  • HA systematic review, 23 articles (n=3928): Juvéderm Ultra most used; tip injected in 13 studies, columella in 12; hump the most common indication; 8 major complications [37217605]
  • Satisfaction review, 8 studies (n=674, mean age 29.5, sex ratio 0.20): satisfied or very satisfied 100% immediately (404/404), 98.2% in following weeks (628/639), 84.7% at 3 months (333/393), 96.4% at 1 year (60/62); effect lasts 8 to 14 months; 1 local infection; most injectors used under 1 mL [33660013]
  • NSR after prior surgical rhinoplasty, 20 articles (n=2,048): HA in 67%; middle-third deformities the main indication; major complications low but increased skin necrosis observed [39230478]
  • African-descent cohort, 487 patients (2018-2021): indications bridge definition 63.9%, alar width 61.6%, bulbous tip 61.6%; median 0.6 mL (0.3-2.1 mL); 0 infection, occlusion, or necrosis [37344935]
  • Narrative review, 80 of 180 articles (1990-2023): early complications asymmetry, injection-site reactions, hypersensitivity; severe complications vascular occlusion, ischemia, necrosis, blindness; also infection, Tyndall effect, nodules, granulomas, scarring, biofilm [39747417]
  • Letter: filler outcomes should be linked to HA rheology — viscosity, elasticity, cohesiveness — which the reviewed studies did not standardize [37783865]
  • Hypothesis: pre-existing facial fillers prolong post-rhinoplasty edema by blocking or compressing lymphatics (hydrophilic, hard, bulky, backflow) [39532285]
  • Saddle nose reconstruction: preoperative HA filler used to expand contracted skin, first reported in this indication [42324394]
  • Largest single-injector series, 5,000 nonsurgical rhinoplasties (2016-2019): dorsal hump the top indication (44%); swelling and erythema in about half; infection 2 (0.04%); localized skin necrosis 3 (0.06%) [32097303]
  • Nonsurgical correction of surgical rhinoplasty complications, 2,088 cases (2018-2022): bridge collapse or asymmetry 49.0%, under-projected tip 44.0%, surface irregularity or scarring 35.4%; mean 0.49 mL; median satisfaction 9 of 10; erythema 36.4% at 2 weeks; skin necrosis 3 (0.47%), all transient [39247575]
  • Secondary liquid rhinoplasty after surgery, 1,122 patients (2004-2025, 6 months or more): complications 2.8%, all minor and transient; satisfaction 92% [41124352]
  • Skin necrosis after hyaluronic acid filler, 7 cases at one center over 2 years: every patient had a cosmetic rhinoplasty more than 3 years earlier [29506052]
  • Systematic review, 23 studies (n=1,600): hyaluronic acid 73.38%, calcium hydroxyapatite 12.44%; about 95% satisfied; 26 minor complications and no vascular event reported, which the authors call likely under-reporting [32590640]
  • Nasal grid protocol, 150 consecutive patients (109 primary, 41 post-surgical; ages 16-60): complications 1.82%; 98.35% scored 8-10 of 10 on correction [30531619]
  • VYC-25L (high G prime) with the grid protocol, 61 patients (74% women, mean age 32): all scored 9-10 of 10 at 2 weeks; 97% self-rated correction adequate; bruising 25%, asymmetry 3%, hematoma 2%; no infection, bumps or necrosis; stable to 6 months [32628267]
  • Rino-4-Puntos technique, 400 patients (71% women), mean 0.65 mL, small midline deep boluses of 0.05 mL or less: no vascular complication; 93% rated outcome at least satisfactory; effect median 11 months [39060796]
  • Modified Rino-4-Puntos for mild to moderate caudal septal deviation appearance, 80 patients: very satisfied 87.5%, satisfied 12.5%; 81.2% reported easier breathing; median 11 months; no vascular event [40416407]
  • Diamond 4-point tip injection, 107 patients, mean 0.12 mL: GAIS excellent in 90.65% at 6 months [37267216]
  • Italian tip technique (two infiltrations, cross-linked HA with lidocaine), 140 patients aged 31-52: all improved 2-3 GAIS grades; morphometric change held from 90 to 180 days (p=0.11); 35 needed a top-up at 2 weeks; no adverse event; Level II [38942953]
  • Cannula-based tip-dorsum-glabella protocol in 528 East Asian patients: length +2.62 mm, projection +3.69 mm, nasolabial angle +5.7 degrees at 9 months in 426 full-protocol patients; FACE-Q satisfaction +44.4; 0 vascular events, 11 transient erythema [42443422]
  • Single medial entry point with a 5 cm 25-gauge cannula reaches every nasal region from the anterior nasal spine to the nasion; proposed to cut vascular and infection risk [35511074]
  • Injector experience, 59 patients treated by 53 injectors: mean 0.45 mL regardless of experience (p=0.374); GAIS higher with more experienced injectors (p<0.001); perceived duration 6-9 months; no vascular event [41813985]
  • FACE-Q before, immediately after and 6 months after rhinofiller, 66 of 83 responders: facial appearance, psychological function and nose satisfaction improved (p<0.05) and the 6-month decline was not significant; Level II [39747421]
  • Rabbit cartilage 90 days after 0.1 mL VYC-20L or VYC-25L: chondrocyte nucleus loss, fibrosis and giant cells differed from saline (p=0.005, 0.018, <0.001); cartilage thickness unchanged; no abscess or necrosis [39965763]
  • European Academy of Facial Plastic Surgery survey, 165 surgeons from 45 countries (mean 116 rhinoplasties a year): 74% operate on filled noses, waiting a mean of 21 weeks; 44% dissolve filler with hyaluronidase before surgery; 76% remove filler during surgery; 25% change their steps; no consensus [39993423]
  • Surgical management of filler complications (fibrosis, granuloma, migration, the Avatar nose): high-frequency ultrasound to find residual filler, hyaluronidase before surgery, open structural reconstruction with autologous cartilage, intraoperative doxycycline, postoperative corticosteroid injections [41412200]
  • Revision after nonsurgical filler in East Asian patients (2018-2024, 1 year or more): complete injectate removal, costal cartilage, septal X framework, rectus fascia dorsum and ePTFE; ROE improved, median VAS 2; Level V [40456990]
  • Rohrich five-principle, five-step liquid rhinoplasty and the 2014 soft-tissue filler special topic set indications and technique for augmenting or refining rather than restructuring [36728574, 24150121]
  • Standardized injection protocol (Radulesco) maps dorsal, paramedian, tip and endonasal sites to droopy, hump, saddle, inverted-V, twisted, revision and valve indications; conservative dosing advised [38627333]
  • Bibliometrics, 197 papers to 2024: USA 61 publications, University of Verona 11, Bertossi the most productive and co-cited author; complication prevention the rising theme [40389737]
  • Free crushed cartilage filler graft (surgical, not injectable) for Asian tip refinement, 66 patients at 16.3 months: length +8.3%, tip height +12.7%; amorphous tip 6.1%, visible graft 4.5%; aesthetic dissatisfaction 12.1%, no revisions [39322839]

Techniques and terms named

hyaluronic acid filler [38862661], calcium hydroxyapatite [38862661], Juvéderm Ultra [37217605], hyaluronidase [42660550], hyperbaric oxygen therapy [42660550], cannula injection [33270498], rheology — viscosity, elasticity, cohesiveness [37783865], Tyndall effect [39747417], granuloma / nodule / biofilm [39747417], vascular occlusion / necrosis [39747417], secondary nonsurgical rhinoplasty after surgery [39230478], filler-assisted skin expansion [42324394], lymphatic drainage hypothesis [39532285], PICOTS framework [33660013], MINORS [37217605], 5,000-case nonsurgical rhinoplasty series [32097303], nonsurgical revision of surgical complications [39247575], secondary liquid rhinoplasty [41124352], post-rhinoplasty necrosis risk [29506052], nasal grid protocol [30531619, 32628267], VYC-25L [32628267], Rino-4-Puntos and modified R4P [39060796, 40416407], diamond injection technique [37267216], Italian tip technique [38942953], cannula tip-dorsum-glabella protocol [42443422], single-entry cannula [35511074], injector experience and GAIS [41813985], FACE-Q after rhinofiller [39747421], rabbit cartilage histology after HA [39965763], EAFPS filler survey [39993423], Avatar nose and ultrasound-guided hyaluronidase [41412200], revision after filler in East Asians [40456990], five-principle liquid rhinoplasty [36728574], soft-tissue fillers special topic [24150121], standardized injection protocol [38627333], bibliometric trend [40389737], free crushed cartilage filler graft [39322839]

Numbers to remember

  • Arterial occlusion 0.27% of 9657 filler patients; satisfaction 99.08% [38862661]
  • Serious events 0.20% of 2488 procedures; OR 1.51 for adverse events after prior surgery [33270519]
  • Full visual recovery in 27% of 22 blindness cases; 82% immediate onset; 57% dorsum injections [42660550]
  • Effect duration 8 to 14 months; 96.4% satisfied at 1 year (60/62) [33660013]
  • 8 major complications in 3928 patients across 23 articles [37217605]
  • Median filler volume 0.6 mL in 487 African-descent patients [37344935]
  • Necrosis 0.06% of 5,000 primary filler treatments; 0.47% of 2,088 post-surgical corrections [32097303, 39247575]
  • 2.8% complications and 92% satisfaction in 1,122 secondary liquid rhinoplasties [41124352]
  • 7 of 7 necrosis cases had prior rhinoplasty [29506052]
  • 0 vascular events in 400 R4P, 528 cannula-protocol and 61 VYC-25L patients [39060796, 42443422, 32628267]
  • Effect median 11 months (R4P), 6-9 months (mixed injectors) [39060796, 41813985]
  • 74% of 165 European surgeons operate on filled noses; 44% dissolve first [39993423]

Numbers

Measure Value Population / study PMID
Revision (surgical) after nonsurgical rhinoplasty Not reported as a rate; 2,088 nonsurgical revisions of surgical noses Single injector, 2018-2022 [39247575]
Top-up injection needed 35 of 140 at 2 weeks Italian tip technique [38942953]
Complication rate, pooled filler rhinoplasty 39.11%, mostly erythema and swelling 30 studies, 9,657 patients [38862661]
Severe arterial occlusion, pooled 0.27% 30 studies, 9,657 patients [38862661]
Adverse events, single injector 7.6% overall; serious 0.20% 2,488 procedures over 10 years [33270519]
Adverse events after prior surgical rhinoplasty 10.8% vs 7.4% (OR 1.51) Same cohort [33270519]
Skin necrosis, primary filler series 0.06% (3/5,000); infection 0.04% 5,000 treatments [32097303]
Skin necrosis, post-surgical filler correction 0.47% (3/2,088), transient 2,088 cases [39247575]
Complications, secondary liquid rhinoplasty 2.8%, minor and transient 1,122 patients [41124352]
Complications, nasal grid protocol 1.82% 150 patients [30531619]
Bruising, asymmetry, hematoma with VYC-25L 25%, 3%, 2% 61 patients [32628267]
Vascular complications, R4P and cannula protocols 0 of 400; 0 of 528; 0 of 80 Three series [39060796]
Vascular events, African-descent cohort 0 of 487 487 patients [37344935]
Full visual recovery after filler blindness 27%, mean 5.3 months 22 cases, 21 articles [42660550]
Satisfaction, pooled filler rhinoplasty 99.08% 30 studies [38862661]
Satisfaction, systematic review About 95% 23 studies, 1,600 patients [32590640]
Satisfaction, secondary liquid rhinoplasty 92% 1,122 patients [41124352]
Satisfaction over time 100% immediate; 84.7% at 3 months; 96.4% at 1 year 8 studies, 674 patients [33660013]
Satisfaction, Rino-4-Puntos 93% at least satisfactory; 87.5% very satisfied (modified) 400 and 80 patients [39060796]
Correction adequate, VYC-25L 97% self-rated; all 9-10 of 10 by evaluator 61 patients [32628267]
GAIS excellent, diamond tip technique 90.65% at 6 months 107 patients [37267216]
FACE-Q satisfaction change, East Asian protocol +44.4 528 patients [42443422]
Median satisfaction VAS, post-surgical correction 9 of 10 2,088 cases [39247575]
Effect duration 8-14 months; median 11; 6-9 Pooled; R4P; mixed injectors [33660013]

What is still contested or missing

  • Complication rates range from 7.6% [33270519] to 39.11% [38862661] depending on whether erythema and swelling are counted [33270519, 38862661]
  • HA rheological properties were not accounted for in the pooled outcome data [37783865]
  • The filler-lymphatic edema mechanism is a hypothesis without objective measurement [39532285]
  • Well-designed RCTs are still lacking [37217605]; commentaries [38977451, 39466798, 38923925, 33270498, 34468422] are title-only on file [37217605, 38977451, 39466798, 38923925, 33270498, 34468422]
  • Vascular events: 0 in 1,600 pooled patients and in three protocol series versus 0.27% severe occlusion in 9,657 pooled patients and 22 published blindness cases; under-reporting is suspected by the reviewers themselves [32590640, 38862661, 42660550]
  • Whether nonsurgical revision should come before surgical revision is a single injector's claim from 2,088 cases [39247575]
  • Filler effect on nasal cartilage shown only in 16 rabbits at 90 days [39965763]
  • No consensus among 165 surgeons on dissolving, timing or removing filler before rhinoplasty [39993423]
  • Injector-experience data are 59 patients across 53 injectors [41813985]

Papers used

  • Pistone ES et al.. Vision Loss Following Nonsurgical Rhinoplasty Injections: Systematic Review of Cases and Management. Aesthet Surg J 2026. PMID 42660550. DOI 10.1093/asj/sjag174
  • Battista RA et al.. Reconstructive Approach to Saddle Nose Deformity: A Diagnostic-Therapeutic Algorithm and the Preoperative Use of Hyaluronic Acid Filler for Skin Expansion in Rhinoplasty. Aesthetic Plast Surg 2026. PMID 42324394. DOI 10.1007/s00266-026-06108-3
  • Caranti A et al.. Complications of Nonsurgical Rhinoplasty with Hyaluronic Acid Injections: A Narrative Review. Aesthetic Plast Surg 2025. PMID 39747417. DOI 10.1007/s00266-024-04636-4
  • Mortada H. Invited Response on: The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic Plast Surg 2025. PMID 38977451. DOI 10.1007/s00266-024-04191-y
  • Maamari SA et al.. Effect of Facial Fillers on Post-rhinoplasty edema: A Hypothesis Based on Literature Review. Facial Plast Surg 2025. PMID 39532285. DOI 10.1055/a-2466-1407
  • Correa T, Owen SR. Invited Commentary on: Santamaría-Gadea et al's "Non-Surgical Rhinoplasty After Rhinoplasty: A Systematic Review of the Technique, Results, and Complications". Facial Plast Surg Aesthet Med 2025. PMID 39466798. DOI 10.1089/fpsam.2024.0267 (title only)
  • Santamaría-Gadea A et al.. Non-Surgical Rhinoplasty After Rhinoplasty: A Systematic Review of the Technique, Results, and Complications. Facial Plast Surg Aesthet Med 2025. PMID 39230478. DOI 10.1089/fpsam.2024.0116
  • Song D et al.. Nonsurgical Rhinoplasty: An Updated Systematic Review of Technique, Outcomes, Complications, and Its Treatments. Aesthetic Plast Surg 2024. PMID 38862661. DOI 10.1007/s00266-024-04161-4
  • Mataro I et al.. The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic Plast Surg 2024. PMID 37783865. DOI 10.1007/s00266-023-03702-7
  • Mortada H et al.. The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic Plast Surg 2024. PMID 37217605. DOI 10.1007/s00266-023-03386-z
  • Yu AY. Discussion: Nonsurgical Rhinoplasty in Patients of African Descent: A Retrospective Review. Plast Reconstr Surg 2024. PMID 38923925. DOI 10.1097/PRS.0000000000011348 (title only)
  • Harb A, Abdul-Razzak A. Nonsurgical Rhinoplasty in Patients of African Descent: A Retrospective Review. Plast Reconstr Surg 2024. PMID 37344935. DOI 10.1097/PRS.0000000000010881
  • Radulesco T et al.. Patient Satisfaction After Non-surgical Rhinoplasty Using Hyaluronic Acid: A Literature Review. Aesthetic Plast Surg 2021. PMID 33660013. DOI 10.1007/s00266-021-02182-x
  • Sulyman O, Dayan S. Commentary on "Nonsurgical Rhinoplasty Using Injectable Fillers: A Safety Review of 2488 Procedures" by Rivkin: Cannula Use During Dermal Filler Injection. Facial Plast Surg Aesthet Med 2021. PMID 33270498. DOI 10.1089/fpsam.2020.0502 (title only)
  • Rivkin A. Nonsurgical Rhinoplasty Using Injectable Fillers: A Safety Review of 2488 Procedures. Facial Plast Surg Aesthet Med 2021. PMID 33270519. DOI 10.1089/fpsam.2020.0291
  • Barone M et al.. The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 Treatments. Plast Reconstr Surg 2021. PMID 34468422. DOI 10.1097/PRS.0000000000008345 (title only)
  • Harb A, Brewster CT. The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 Treatments. Plast Reconstr Surg 2020. PMID 32097303. DOI 10.1097/PRS.0000000000006554
  • Harb A, Abdul-Razzak A. Nonsurgical Correction of Surgical Rhinoplasty Complications with Hyaluronic Acid Fillers: A Retrospective Review of 2088 Cases. Plast Reconstr Surg Glob Open 2024. PMID 39247575. DOI 10.1097/GOX.0000000000006126
  • Valente DS, Zanella RK. Secondary Liquid Rhinoplasty: Challenges, Techniques, and Long-term Outcomes. Aesthet Surg J 2026. PMID 41124352. DOI 10.1093/asj/sjaf212
  • Robati RM et al.. The Risk of Skin Necrosis Following Hyaluronic Acid Filler Injection in Patients With a History of Cosmetic Rhinoplasty. Aesthet Surg J 2018. PMID 29506052. DOI 10.1093/asj/sjy005
  • Williams LC et al.. Nonsurgical Rhinoplasty: A Systematic Review of Technique, Outcomes, and Complications. Plast Reconstr Surg 2020. PMID 32590640. DOI 10.1097/PRS.0000000000006892
  • Bertossi D et al.. Nonsurgical Rhinoplasty: Nasal Grid Analysis and Nasal Injecting Protocol. Plast Reconstr Surg 2019. PMID 30531619. DOI 10.1097/PRS.0000000000005224
  • Bertossi D et al.. Nonsurgical Rhinoplasty With the Novel Hyaluronic Acid Filler VYC-25L: Results Using a Nasal Grid Approach. Aesthet Surg J 2021. PMID 32628267. DOI 10.1093/asj/sjaa196
  • Silikovich F, Kroumpouzos G. Nonsurgical Rhinoplasty: Results from a Retrospective Study of Rino-4-Puntos Technique with Hyaluronic Acid. Aesthetic Plast Surg 2025. PMID 39060796. DOI 10.1007/s00266-024-04263-z
  • Silikovich F, Kroumpouzos G. Nonsurgical Rhinoplasty: A Modified Rino-4-Puntos Technique With Hyaluronic Acid Improves the Appearance of Nasal Septal Deviation. Plast Reconstr Surg Glob Open 2025. PMID 40416407. DOI 10.1097/GOX.0000000000006801
  • Betti E et al.. Nonsurgical Rhinoplasty: Diamond Injection Technique for Nasal Tip Contouring. Facial Plast Surg Aesthet Med 2024. PMID 37267216. DOI 10.1089/fpsam.2023.0006
  • Scarano A et al.. The Use of Cross-Linked Hyaluronic Acid in Non-surgical Rhinoplasty Using Italian Technique. Aesthetic Plast Surg 2025. PMID 38942953. DOI 10.1007/s00266-024-04197-6
  • Ye J et al.. A Cannula-Based Sequential Injection Protocol for Non-surgical Rhinoplasty in East Asian Patients. Aesthetic Plast Surg 2026. PMID 42443422. DOI 10.1007/s00266-026-06110-9
  • Radulesco T et al.. A Safe Nonsurgical Rhinoplasty Procedure. Plast Reconstr Surg 2022. PMID 35511074. DOI 10.1097/PRS.0000000000009226
  • Germani M et al.. Standardized Non-surgical Rhinoplasty with Hyaluronic Acid: Consistent Outcomes Across Injectors with Varying Experience. Aesthetic Plast Surg 2026. PMID 41813985. DOI 10.1007/s00266-026-05723-4
  • Lombardo GAG et al.. Assessing the Long-Term Impact of Non-Surgical Rhinoplasty on Patient Satisfaction and Quality of Life: A Prospective Study Using FACE-Q. Aesthetic Plast Surg 2025. PMID 39747421. DOI 10.1007/s00266-024-04644-4
  • Gürlek İÖ et al.. Nonsurgical Rhinoplasty: Histopathological Effects of Dermal Fillers on Nasal Cartilage in a Rabbit Model. Facial Plast Surg 2026. PMID 39965763. DOI 10.1055/a-2541-2508
  • Vansteelant G et al.. Facial Fillers and Surgical Rhinoplasty: Cross-Sectional Study. Facial Plast Surg 2025. PMID 39993423. DOI 10.1055/a-2535-0108
  • Wong EHC, D'Souza A. Surgical Management of Filler Rhinoplasty Complications. Facial Plast Surg 2025. PMID 41412200. DOI 10.1055/a-2764-3235
  • Ye J et al.. Revision Rhinoplasty After Non-Surgical Filler in East Asian Patients: A Safe and Effective Surgical Approach. Aesthetic Plast Surg 2025. PMID 40456990. DOI 10.1007/s00266-025-04963-0
  • Rohrich RJ et al.. Five-Principle and Five-Step Liquid Rhinoplasty. Plast Reconstr Surg 2023. PMID 36728574. DOI 10.1097/PRS.0000000000010162
  • Kurkjian TJ et al.. Soft-tissue fillers in rhinoplasty. Plast Reconstr Surg 2014. PMID 24150121. DOI 10.1097/01.prs.0000437246.61294.33
  • Radulesco T et al.. Advancing the Era of Liquid Rhinoplasty: A Methodological Approach to Injection Protocols. Aesthetic Plast Surg 2024. PMID 38627333. DOI 10.1007/s00266-024-04025-x
  • Liao Z et al.. The Research Trend of Non-surgical Rhinoplasty: A Bibliometric and Visualized Analysis. Aesthetic Plast Surg 2025. PMID 40389737. DOI 10.1007/s00266-025-04914-9
  • Chang BL et al.. Free Crushed Cartilage Filler Graft to Optimize Tip Aesthetics in Asian Rhinoplasty. Aesthetic Plast Surg 2025. PMID 39322839. DOI 10.1007/s00266-024-04369-4

Written by rhinoplasty.cc, 2026-09-08, from the PubMed abstracts; not medical advice.

Start here

The 40 papers the synthesis above was written from.

  1. ASJ
    2026PMID 42660550Summary
  2. APS
    2026PMID 42324394Summary
  3. APS
    2025PMID 39747417Summary
  4. APS
    2025PMID 38977451Summary
  5. FPS
    2025PMID 39532285Summary
  6. FPSAM
    2025PMID 39466798
  7. FPSAM
    2025PMID 39230478Summary
  8. APS
    2024PMID 38862661Summary
  9. APS
    2024PMID 37783865Summary
  10. APS
    2024PMID 37217605Summary
  11. PRS
    2024PMID 38923925
  12. PRS
    2024PMID 37344935Summary
  13. APS
    2021PMID 33660013Summary
  14. FPSAM
    2021PMID 33270498
  15. FPSAM
    2021PMID 33270519Summary
  16. PRS
    2021PMID 34468422
  17. PRS
    2020PMID 32097303Summary
  18. PRS-GO
    2024PMID 39247575Summary
  19. ASJ
    2026PMID 41124352Summary
  20. ASJ
    2018PMID 29506052Summary
  21. PRS
    2020PMID 32590640Summary
  22. PRS
    2019PMID 30531619Summary
  23. ASJ
    2021PMID 32628267Summary
  24. APS
    2025PMID 39060796Summary
  25. PRS-GO
    2025PMID 40416407Summary
  26. FPSAM
    2024PMID 37267216Summary
  27. APS
    2025PMID 38942953Summary
  28. APS
    2026PMID 42443422Summary
  29. PRS
    A Safe Nonsurgical Rhinoplasty Procedure
    Radulesco T, Braccini F, Kestemont P et al.
    2022PMID 35511074Summary
  30. APS
    2026PMID 41813985Summary
  31. APS
    2025PMID 39747421Summary
  32. FPS
    2026PMID 39965763Summary
  33. FPS
    Facial Fillers and Surgical Rhinoplasty: Cross-Sectional Study
    Vansteelant G, D'Souza A, EAFPS Filler Working Group
    2025PMID 39993423Summary
  34. FPS
    2025PMID 41412200Summary
  35. APS
    2025PMID 40456990Summary
  36. PRS
    Five-Principle and Five-Step Liquid Rhinoplasty
    Rohrich RJ, Novak M, Alleyne B et al.
    2023PMID 36728574Summary
  37. PRS
    Soft-tissue fillers in rhinoplasty
    Kurkjian TJ, Ahmad J, Rohrich RJ
    2014PMID 24150121Summary
  38. APS
    2024PMID 38627333Summary
  39. APS
    2025PMID 40389737Summary
  40. APS
    2025PMID 39322839Summary

Related topics

17

Complications and management

17 of the 88 papers here also match this topic.

Open topic
13

Outcomes, satisfaction and psychology

13 of the 88 papers here also match this topic.

Open topic
9

Anatomy and nasal analysis

9 of the 88 papers here also match this topic.

Open topic
6

Ethnic, Asian, Middle Eastern, African and Latino rhinoplasty

6 of the 88 papers here also match this topic.

Open topic

Every paper, by year

88 papers. The 40 Start here papers are not repeated.

20266 papers · 6 above
202517 papers · 14 above
  1. APS
    PMID 39690201
  2. APS
    PMID 39849099
  3. FPSAM
    PMID 39570692
202411 papers · 8 above
  1. FPSAM
    PMID 39166301
  2. FPSAM
    PMID 39591585
  3. FPSAM
    PMID 39172533
20232 papers · 1 above
  1. CPS
    Liquid Rhinoplasty
    Saad N, Stallworth CL
    PMID 37169410Summary
202211 papers · 1 above
  1. APS
    PMID 34109452Full text
  2. CPS
    Nonsurgical Rhinoplasty
    Rohrich R, Alleyne B, Novak M et al.
    PMID 34782136Summary
  3. FPS
    PMID 35158387Summary
  4. FPSAM
    PMID 34448622
  5. FPS Clin
    PMID 35501055Summary
  6. FPS Clin
    Liquid Rhinoplasty
    Saad N, Stallworth CL
    PMID 35934437Summary
  7. FPS Clin
    PMID 35501057Summary
  8. FPS Clin
    PMID 35501050Summary
  9. PRS-GO
    PMID 35402124Summary
  10. PRS-GO
    PMID 35999875Summary
202111 papers · 5 above
  1. APS
    PMID 33782723
  2. APS
    PMID 33616714Summary
  3. APS
    PMID 33216177Summary
  4. PRS
    PMID 33027204
  5. PRS
    PMID 33961592
  6. PRS
    PMID 33760777
20207 papers · 2 above
  1. APS
    PMID 32072215
  2. APS
    PMID 31832736Summary
  3. APS
    Psychological Analysis of Non-surgical Rhinoplasty
    Di Rosa L, Cerulli G, De Pasquale A
    PMID 31768580Summary
  4. PRS-GO
    PMID 33425572Summary
  5. PRS-GO
    PMID 32983752Full text
20198 papers · 1 above
  1. APS
    PMID 30560283Summary
  2. APS
    PMID 30535556Summary
  3. FPS
    PMID 31307095Summary
  4. FPS
    PMID 30759462
  5. FPS Clin
    PMID 31280849Summary
  6. PRS
    PMID 31348378
  7. PRS-GO
    Nonsurgical Rhinoplasty: A Graft-based Technique
    Segreto F, Marangi GF, Cerbone V et al.
    PMID 31624669Summary
20185 papers · 1 above
  1. ASJ
    PMID 29788065
  2. ASJ
    PMID 30265278
  3. FPS
    PMID 29857337Summary
  4. FPS Clin
    PMID 30005788Summary
20172 papers
  1. APS
    PMID 28130558Summary
  2. JAMA FPS
    PMID 28492936
20163 papers
  1. CPS
    PMID 26616716Summary
  2. FPS
    Nonsurgical Rhinoplasty
    Johnson ON 3rd, Kontis TC
    PMID 27680521Summary
  3. PRS-GO
    PMID 27200245Summary
20151 papers
  1. FPS
    PMID 26126227Summary
20141 papers · 1 above
20131 papers
  1. FPS Clin
    PMID 23731585Summary
20122 papers
  1. APS
    PMID 22350307Summary
  2. PRS
    Multiplane hyaluronic acid rhinoplasty
    Xue K, Chiang CA, Liu K et al.
    PMID 22286467